|
MED13 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.791800E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.894440E-02 |
| Normal-vs-Stage2 |
4.333800E-01 |
| Normal-vs-Stage3 |
5.375400E-01 |
| Normal-vs-Stage4 |
8.075800E-01 |
| Stage1-vs-Stage2 |
6.892000E-01 |
| Stage1-vs-Stage3 |
4.478400E-01 |
| Stage1-vs-Stage4 |
4.632400E-01 |
| Stage2-vs-Stage3 |
8.323600E-01 |
| Stage2-vs-Stage4 |
5.884800E-01 |
| Stage3-vs-Stage4 |
6.539000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.111230E-01 |
| Normal-vs-AfricanAmerican |
2.011600E-02 |
| Normal-vs-Asian |
3.506800E-01 |
| Caucasian-vs-AfricanAmerican |
3.152600E-01 |
| Caucasian-vs-Asian |
7.254000E-01 |
| AfricanAmerican-vs-Asian |
9.289200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.856900E-03 |
| Normal-vs-Female |
3.674000E-01 |
| Male-vs-Female |
1.440230E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.625600E-01 |
| Normal-vs-Extreme_Weight |
3.924200E-03 |
| Normal-vs-Obese |
2.637400E-01 |
| Normal-vs-Extreme_Obese |
1.776850E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.818400E-01 |
| Normal_Weight-vs-Obese |
7.646000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.846600E-01 |
| Extreme_Weight-vs-Obese |
1.375750E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.674200E-01 |
| Obese-vs-Extreme_Obese |
4.590400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.415200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.907400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.004660E-03 |
| Normal-vs-Age(81-100Yrs) |
8.27640000000684E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.361000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.331920E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.158400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.295300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.317770E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.270800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.565900E-02 |
| Normal-VS-Type2 PRCC |
2.718500E-02 |
| Normal-VS-KIRP CIMP |
4.454200E-01 |
| Normal-VS-Unclassified PRCC |
8.969800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.210600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.323500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.407400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.479800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.170430E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.526600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.884490E-03 |
| Normal-vs-N1 |
4.553200E-01 |
| Normal-vs-N2 |
7.227800E-01 |
| N0-vs-N1 |
4.579800E-02 |
| N0-vs-N2 |
4.726000E-01 |
| N1-vs-N2 |
8.548000E-01 |
|
|
